Contrast Media Injector Market By Product Type (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Heads, Syringes), Accessories), By Application (Radiology, Interventional Cardiology), and By Region - Overall In-depth Analysis, Global Market Share, Top Trends, Professional & Technical Industry Insights 2024 - 2030

According to Syndicate Market Research, the global contrast media injector market size in terms of revenue was valued at around USD 1.42 billion in 2023 and is expected to reach a value of USD 2.37 billion by 2030, growing at a CAGR of roughly 5.86% from 2024 to 2030. The global contrast media injector market is projected to grow at a significant growth rate due to a number of driving factors.

Contrast Media Injector Market: Overview

To enhance the quality of images produced by diagnostic imaging techniques like CT and MRI scans, contrast media injectors are utilized to regulate contrast material. To prevent physicians from inadvertently administering contrast fluid, contrast media injectors are equipped with safety mechanisms and pre-established protocols. Contrast material injection errors that result in adverse effects, such as the formation of air emboli, may be mitigated with the use of counter-media injectors.

Injectors have a significantly increase contrast because they diminish the quantity of contrast seen. The medical imaging procedures sector is home to a diverse array of contrast media agents and injector systems, and the contrast media agent and injector system market is a sector notable for its rapid expansion.

Key Highlights

• The contrast media injector market registered a CAGR of 5.86% during the forecast period.
• The market is propelled by advancements in technology, the prevalence of chronic diseases, and the need for rapid and accurate diagnosis.
• On the basis of Product Type, the consumables segment has a significant share of the market and is expected to increase at the fastest CAGR.
• Based on application, Radiology is the largest segment due to its growing use in CT, MRI, and diagnostic imaging.
• North America region is predicted to grow as a leader in the contrast media injector market.

Contrast Media Injector Industry Dynamics:

Growth Drivers

• Growing frequency of chronic diseases

On an international scale, the prevalence of cancer has increased substantially. By 2023, the percentage of the population afflicted with cancer is projected to rise by 50%, reaching 15 million. Contrast media injectors are utilized during diagnostic imaging to increase patient safety and image quality by injecting contrast media. Consequently, the rise in cancer and cardiovascular disease incidence will propel the need for enhanced medical infrastructure and sophisticated diagnostic imaging techniques, thereby influencing the trajectory of the contrast media injector market.

Global Contrast Media Injector Market 2024 Size By Region

Get more information about this report - Request Free Sample Copy

Restraints:

• Expensive contrast medium injectors

The price of contrast media injectors differs depending on the injector brand that medical facilities support. Because reusing the same tube and syringe is not feasible due to concerns regarding hygiene and safety, the expenditure on consumables is recurring. As with tubes and syringes, this places a significant burden on end consumers and increases the price of contrast media injector systems.

Opportunities

• IT-enabled contrast media injector solutions

Numerous contrast media injector manufacturers are devoting resources to the development of software that can access information on injection speed, flow rate, contrast media type, and pressure through real-time data analysis. This data contributes to the mitigation of errors and the enhancement of operational efficiencies. As a consequence, contrast media injectors have a tremendous amount of future market expansion potential. Future potential is also being generated by power contrast injectors, MRI contrast injectors, CT scan contrast media injectors, syringeless injectors, and syringe-free injection systems.

Contrast Media Injector Market: Segmentation Analysis

The global contrast media injector market is segmented by product type, application, end-user, and region.

Product Type Insights

Based on product type, the contrast media injector market is divided into injector systems and consumables. Consumables comprise needles, injector cartridges, and contrast medium, Various consumables are necessary for the operation of medical imaging businesses. Because single-use injectors and accessories are growing steadily in demand, consumables are predicted to grow at the highest CAGR of 8.3% during the forecast period.

Syringeless, single-head, and dual-head injectors with advanced capabilities such as data storage, automated injection, and dose management are included in the injector systems segment. In 2023, the injector systems dominated the market and brought in over 60.9% of total revenue worldwide. The robust growth rate observed in this particular sector can be attributed to the increasing need for consumables that guarantee confidentiality and hygiene throughout diagnostic procedures.

Application Insights

By application, the contrast media injector market is divided into radiology, interventional radiology, and interventional cardiology. Because of its growing application in CT, MRI, and other diagnostic imaging techniques, radiology makes up a major share of the market. In 2023, radiology dominated the market and generated over 47.1% of worldwide revenue. Due to its application in procedures such as angioplasty and stenting, interventional radiology is predicted to expand somewhat and interventional cardiology to develop greatly. These techniques include CT-guided biopsies and MRI-guided ablation.

Recent Developments

• Medtronic declared the Infuse injector, its latest contrast media injector system, to be commercially available in the United States in August 2024. A single-use, impermanent injector, the Infuse injector is intended to be more efficient and user-friendly than existing systems. It incorporates several novel attributes, including an intuitive touchscreen interface and an integrated camera.
• GE Healthcare said in November 2023 that it would invest USD 80 million to expand its capacity for producing contrast media. GE Healthcare plans to increase the annual production of contrast media by 30 million by 2025, which should accelerate market expansion shortly.

Contrast Media Injector Market: Regional Analysis

• North America is expected to have the fastest growth

A rise in the prevalence of chronic diseases resulting from lifestyle changes and an increase in the demand for minimally invasive procedures are anticipated to propel North America to the lead of the market during the forecast period. In 2023, North America held a significant market share of over 38.4% in terms of global revenue. This region's well-established healthcare facilities, easy access to new technologies, and high demand for diagnostic procedures are likely to drive inpatient exams and market growth. Since chronic diseases and deadly injuries are common, hospital admissions have increased in the U.S. and Canada.

The Asia-Pacific market for contrast media injectors will increase by 8.5%. This industry is propelled by quickly developing nations, expanding healthcare knowledge, and an aging population. It is anticipated that an aging population and an increase in the prevalence of chronic diseases, such as neurological disorders, will stimulate demand for contrast media injectors. Neurological disorders are inextricably linked to aging and typically manifest in individuals older than sixty. The high demand for sophisticated surgical treatment options for these disorders should stimulate the demand for contrast media injectors.

Contrast Media Injector Market: Competitive Landscape

Some of the major players in the global contrast media injectors market include:

• APOLLO RT Co. Ltd.
• Bayer Ag
• Bracco Imaging S.P.A.
• GE Company
• Guerbet Group
• Medtron AG RT Co. Ltd.
• Nemoto Kyorindo Co. Ltd.
• Shenzen Seacrown Electromechanical Co. Ltd.
• Sino Medical-Device Technology Co. Ltd.

The global contrast media injectors market is segmented as follows:

By Product Type

• Injector Systems
• Consumables

By Application

• Radiology
• Interventional Radiology
• Interventional Cardiology

By End-User

• Ambulatory Surgical Centers (ASCs)
• Diagnostic Centers
• Hospitals

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • U.K.
  • France
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• The Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East Africa

Frequently Asked Questions:

What are the key factors driving global contrast media injectors market growth?

The innovations in technology and growing demand for minimally-invasive surgeries are key factors of contrast media injectors market expansion.

What will be the CAGR of the global contrast media injectors market?

The global contrast media injectors market is growing at a CAGR of around 5.86% during the forecast period (2024-2030).

What will be the value of the contrast media injectors market during 2024- 2030?

According to Syndicate Market Research, the global contrast media injectors market size was estimated at approximately USD 1.42 billion in 2023 and is expected to generate revenue of around USD 2.37 billion by 2030.

Which region will drive global contrast media injectors market revenue?

North America region will dominate the global contrast media injectors market.

Who are the key players operating in the global contrast media injectors market growth?

Some major players covered in the global contrast media injectors market are; APOLLO RT Co. Ltd., Bayer Ag, Bracco Imaging S.P.A., GE Company, Guerbet Group, Medtron AG RT Co. Ltd., Nemoto Kyorindo Co. Ltd., Shenzen Seacrown Electromechanical Co. Ltd., Sino Medical-Device Technology Co. Ltd., and others.

Frequently Asked Questions

List of Figures

List of Tables

• Bayer Ag (Germany)
• Bracco Imaging S.P.A (Italy)
• Guerbet Group (France)
• Ulrich GmbH & Co. KG (Germany)
• Nemoto Kyorindo Co. Ltd (Japan)
• Sino Medical-Device Technology Co. Ltd (Sinomdt) (China)
• APOLLO RT Co. Ltd. (Hongkong)
• Shenzhen Anke High-tech Co. Ltd (China)
• Shenzen Seacrown Electromechanical Co Ltd. (China)
• Medtron AG (Germany)

Request Sample

An Overview on Research Methodology used at Syndicate Market Research:

1.1 Research Methodology

The process of market research at Syndicate Market Research is an iterative in nature and usually follows following path. Information from secondary is used to build data models, further the results obtained from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new information is again incorporated into data model. The process continues till desired level of information is not generated.

To calculate the market size, the report considers the revenue generated from the sales of the market providers. The revenue generated from the sales of market is calculated through primary and secondary research. The key players operating in the market across the globe are identified through secondary research and a corresponding detailed analysis of the top vendors in the market is done. The market size calculation also includes clinical trial phase segmentation determined using secondary sources and verified through primary sources.

1.2 Secondary Research

The secondary research sources that are typically referred to include, but are not limited to:

• Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
• Internal and external proprietary databases, relevant patent and regulatory databases
• National government documents, statistical databases and market reports
• News articles, press releases and web-casts specific to the companies operating in the market

The sources for secondary research includes but is not limited to: Factiva, Hoovers and Statista

1.3 Primary Research

We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:

• It provides first-hand information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
• Helps in validating and strengthening the secondary research findings
• Further develops the analysis team’s expertise and market understanding
• Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

The participants who typically take part in such a process include, but are not limited to:

• Industry participants: CEOs, VPs, marketing/ clinical trial phase managers, market intelligence managers and national sales managers
• Purchasing managers, technical personnel, distributors and resellers
• Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
• Key opinion leaders specializing in different areas corresponding to different industry end users

1.4 Models

Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data types to produce estimates:

• Demographic data: Population split by segment
• Macro-economic indicators: GDP, etc.
• Industry indicators: Expenditure, infrastructure, sector growth and facilities.

Data is then cross checked by the expert panel.

1.4.1 Company Share Analysis Model

Company share analysis is used to derive the size of global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps:

1.4.2 Revenue Based Modeling

Revenue based models can be built in two ways - Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.

1.5 Research Limitations

Inflation is not a part of pricing in this report. Prices of the products and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each type has been taken into account while estimating and forecasting market revenue on a global basis. Regional average price has been considered while breaking down this market by end user in each region.